SCHEMBL8934503

SCHEMBL8934503

COc1ccc(-c2cc(=O)c3cccc(C(C)C)c3o2)cc1O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 3/20 0.67
▸ CSNK2A2 P19784 5/20 0.56
▸ CSNK2B P67870 5/20 0.56
▸ CSNK2A1 P68400 5/20 0.56
▸ PTGES O14684 2/20 0.56
▸ CYP3A4 P08684 3/20 0.54
▸ MAPT P10636 3/20 0.54
▸ HPGD P15428 3/20 0.54
▸ CYP2C9 P11712 2/20 0.54
▸ CYP2C19 P33261 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ ABCC1 P33527 2/20 0.54
▸ ABCB1 P08183 2/20 0.54
▸ ABCG2 Q9UNQ0 1/20 0.54
▸ KDM4E B2RXH2 2/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ MAPK1 P28482 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ POLB P06746 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8934531 0.89 ABCB1 (0.67) TERTCSNK2A2CSNK2BCSNK2A1CYP3A4
SCHEMBL22230879 0.85 TERT (0.69) TERTCSNK2A2CSNK2BCSNK2A1PTGES
SCHEMBL6612048 0.82 TERT (0.88) TERTCSNK2A2CSNK2BCSNK2A1PTGES
SCHEMBL6614126 0.81 TERT (1.00) TERTCSNK2A2CSNK2BCSNK2A1CYP3A4
SCHEMBL6613755 0.81 TERT (0.77) TERTCSNK2A2CSNK2BCSNK2A1CYP3A4
SCHEMBL6614365 0.80 TERT (0.80) TERTCSNK2A2CSNK2BCSNK2A1CYP3A4
SCHEMBL5320080 0.79 KDM4E (0.81) TERTCSNK2A2CSNK2BCSNK2A1PTGES
SCHEMBL6129133 0.77 TUBB4A (0.71) TERTCYP3A4MAPTALDH1A1MAPK1
SCHEMBL13264829 0.77 CYP1B1 (0.60) TERTCYP3A4MAPTHPGDCYP2C9
SCHEMBL6613454 0.76 TERT (1.00) TERTCSNK2A2CSNK2BCSNK2A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 — — WO claimed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 — — WO disclosed
Send feedback